Thule Group net sales for the fourth quarter increased 7.2% year-over-year thanks to revenue from Thule's recent acquisition, ...

We tested the best hitch bike racks for 2025 with options for every budget. Top picks include Thule, Kuat, RockyMounts, and more.

Amazon Thule Helium Platform Hitch Bike Rack 2 Bike on sale, Thule Helium Platform XT on sale, Thule Helium Platform 2 Review Switchback Travel on sale, Thule Helium Platform XT on sale, 1ST LOOK ...

Thule T2 Pro XTR 2 Bike Platform Hitch Rack on sale, T2 Pro XTR 2 Bike Hitch Rack 2 on sale, Thule T2 Pro XTR Hitch Bike Rack on sale, K at s Piston Pro X Hitch Bike Rack Is One Hand Operable Extra on ...

The Shifts&Grins hitch rack is made to carry two bikes, and is designed to make installing the rack to your car and mounting your bike to the rack frustration free. It also boasts two neat features ...

Of all the things your keep in your garage, a bike can be one of the trickiest to store. This DIY bike rack design will help ...

Revenue surged by 15.6% year over year to $2.91 billion. Non-GAAP earnings per share of $3.98 missed expectations. R&D and SG&A expenses rose by 22.9%, impacting operating margins. Revenue $2.91 ...

Vertex stock trades at 23.8 times forward earnings (in line with the S&P 500), with $11.2 billion in cash and strong growth prospects. The healthcare sector has struggled to deliver worthwhile ...

I have one standard rack appliance in my home: a Unifi Dream Machine Pro. It is mounted horizontally in a coat closet, putting it close to my home's fiber input and also incidentally keeping our ...

In the skies ahead and above them, from left to right, is a F/A-18F Super Hornet with Strike Fighter Squadron (VFA) 2, a F-35C Lightning II assigned to Strike Fighter Squadron (VFA) 97 ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Vertex Pharmaceuticals performed well for much of 2024. In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful lumbosacral ...